vs
Bioceres Crop Solutions Corp.（BIOX）与美盛公司（MOS）财务数据对比。点击上方公司名可切换其他公司
美盛公司的季度营收约是Bioceres Crop Solutions Corp.的38.3倍（$3.0B vs $77.6M）。Bioceres Crop Solutions Corp.净利率更高（-9.6% vs -17.5%，领先7.9%）。美盛公司同比增速更快（5.6% vs -16.8%）。过去两年美盛公司的营收复合增速更高（5.3% vs -8.4%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
美盛公司（The Mosaic Company）是总部位于美国佛罗里达州坦帕的化工企业，主营磷矿、钾矿开采及尿素采集，依托多元国际分销网络和旗下肥料业务板块生产销售农用肥料，是美国规模最大的钾肥、磷肥生产商。
BIOX vs MOS — 直观对比
营收规模更大
MOS
是对方的38.3倍
$77.6M
营收增速更快
MOS
高出22.4%
-16.8%
净利率更高
BIOX
高出7.9%
-17.5%
两年增速更快
MOS
近两年复合增速
-8.4%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $3.0B |
| 净利润 | $-7.4M | $-519.5M |
| 毛利率 | 46.8% | 11.5% |
| 营业利润率 | 9.3% | -3.4% |
| 净利率 | -9.6% | -17.5% |
| 营收同比 | -16.8% | 5.6% |
| 净利润同比 | -20.2% | -407.4% |
| 每股收益（稀释后） | $-0.12 | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXMOS
| Q4 25 | — | $3.0B | ||
| Q3 25 | $77.6M | $3.5B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | $60.6M | $2.6B | ||
| Q4 24 | $98.8M | $2.8B | ||
| Q3 24 | $93.3M | $2.8B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | $84.0M | $2.7B |
净利润BIOXMOS
| Q4 25 | — | $-519.5M | ||
| Q3 25 | $-7.4M | $411.4M | ||
| Q2 25 | — | $410.7M | ||
| Q1 25 | $-1.6M | $238.1M | ||
| Q4 24 | $605.2K | $169.0M | ||
| Q3 24 | $-6.2M | $122.2M | ||
| Q2 24 | — | $-161.5M | ||
| Q1 24 | $9.8M | $45.2M |
毛利率BIOXMOS
| Q4 25 | — | 11.5% | ||
| Q3 25 | 46.8% | 16.0% | ||
| Q2 25 | — | 17.3% | ||
| Q1 25 | 39.4% | 18.6% | ||
| Q4 24 | 42.0% | 10.7% | ||
| Q3 24 | 40.2% | 14.8% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | 50.8% | 14.9% |
营业利润率BIOXMOS
| Q4 25 | — | -3.4% | ||
| Q3 25 | 9.3% | 9.8% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | 1.5% | 12.9% | ||
| Q4 24 | 14.5% | 3.5% | ||
| Q3 24 | 2.5% | 4.1% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | 15.7% | 6.5% |
净利率BIOXMOS
| Q4 25 | — | -17.5% | ||
| Q3 25 | -9.6% | 11.9% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | -2.6% | 9.1% | ||
| Q4 24 | 0.6% | 6.0% | ||
| Q3 24 | -6.6% | 4.3% | ||
| Q2 24 | — | -5.7% | ||
| Q1 24 | 11.6% | 1.7% |
每股收益（稀释后）BIOXMOS
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $-0.12 | $1.29 | ||
| Q2 25 | — | $1.29 | ||
| Q1 25 | $-0.02 | $0.75 | ||
| Q4 24 | $0.00 | $0.53 | ||
| Q3 24 | $-0.10 | $0.38 | ||
| Q2 24 | — | $-0.50 | ||
| Q1 24 | $0.14 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $276.6M |
| 总债务越低越好 | — | $4.3B |
| 股东权益账面价值 | $288.3M | $12.1B |
| 总资产 | $734.9M | $24.5B |
| 负债/权益比越低杠杆越低 | — | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资BIOXMOS
| Q4 25 | — | $276.6M | ||
| Q3 25 | $15.5M | $153.3M | ||
| Q2 25 | — | $286.2M | ||
| Q1 25 | $38.5M | $259.2M | ||
| Q4 24 | $29.2M | $272.8M | ||
| Q3 24 | $32.3M | $301.6M | ||
| Q2 24 | — | $322.0M | ||
| Q1 24 | $16.4M | $336.7M |
总债务BIOXMOS
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $3.4B | ||
| Q2 25 | — | $3.3B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.2B | ||
| Q1 24 | — | $3.2B |
股东权益BIOXMOS
| Q4 25 | — | $12.1B | ||
| Q3 25 | $288.3M | $12.8B | ||
| Q2 25 | — | $12.4B | ||
| Q1 25 | $345.0M | $11.8B | ||
| Q4 24 | $346.3M | $11.5B | ||
| Q3 24 | $346.0M | $11.8B | ||
| Q2 24 | — | $11.7B | ||
| Q1 24 | $348.5M | $12.0B |
总资产BIOXMOS
| Q4 25 | — | $24.5B | ||
| Q3 25 | $734.9M | $24.7B | ||
| Q2 25 | — | $24.3B | ||
| Q1 25 | $798.2M | $23.2B | ||
| Q4 24 | $835.2M | $22.9B | ||
| Q3 24 | $827.3M | $23.3B | ||
| Q2 24 | — | $22.6B | ||
| Q1 24 | $836.1M | $22.9B |
负债/权益比BIOXMOS
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.27× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-56.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-405.7M |
| 自由现金流率自由现金流/营收 | — | -13.6% |
| 资本支出强度资本支出/营收 | — | 11.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-534.6M |
8季度趋势，按日历期对齐
经营现金流BIOXMOS
| Q4 25 | — | $-56.1M | ||
| Q3 25 | $14.4M | $228.5M | ||
| Q2 25 | — | $609.5M | ||
| Q1 25 | $23.3M | $42.9M | ||
| Q4 24 | $-5.4M | $219.3M | ||
| Q3 24 | $5.2M | $312.9M | ||
| Q2 24 | — | $847.0M | ||
| Q1 24 | $-17.4M | $-80.0M |
自由现金流BIOXMOS
| Q4 25 | — | $-405.7M | ||
| Q3 25 | — | $-135.9M | ||
| Q2 25 | — | $304.9M | ||
| Q1 25 | — | $-297.9M | ||
| Q4 24 | — | $-74.8M | ||
| Q3 24 | — | $72.1M | ||
| Q2 24 | — | $513.1M | ||
| Q1 24 | — | $-463.0M |
自由现金流率BIOXMOS
| Q4 25 | — | -13.6% | ||
| Q3 25 | — | -3.9% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | -11.4% | ||
| Q4 24 | — | -2.7% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | — | 18.2% | ||
| Q1 24 | — | -17.3% |
资本支出强度BIOXMOS
| Q4 25 | — | 11.8% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | 13.0% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | — | 8.6% | ||
| Q2 24 | — | 11.9% | ||
| Q1 24 | — | 14.3% |
现金转化率BIOXMOS
| Q4 25 | — | — | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 0.18× | ||
| Q4 24 | -8.85× | 1.30× | ||
| Q3 24 | — | 2.56× | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | -1.77× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
